Meta-analysis of 4 trials (659 participants; 3 candesartan, 1 telmisartan): angiotensin receptor blockers reduced migraine days by 1.00/month and headache days by 1.21/month vs control; responder OR 2.68. Certainty low for migraine days.
Meta-analysisn = 659
Riise et al. The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis